Cerebral atrophy is an independent risk factor for unfavorable outcome after spontaneous supratentorial intracerebral hemorrhage
From the 1950s to the 1990s, doctors prescribed amphetamines to decrease a patients appetite and help stimulate weight loss
SeekPeptides members access comprehensive tracking tools, protocol databases, and community insights that help optimize GLP-1 treatment from the first dose through long-term maintenance
SM biology and obesity-related changes Women face a double-edged sword with GLP-1s: While women often lose more total weight on these drugs, this also means they tend to lose more absolute muscle mass compared to men, raising specific concerns for this group
Easy dosing (2.5 mg/mL) works well for very small doses and precise measurements
These receptor agonists are recognized for their cardioprotective properties and have been approved by the FDA to lower the risk of major adverse cardiovascular events in individuals who are overweight or obese with cardiovascular disease